Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin: A morphologic study

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 6, 1997, Pages 1937-1944

  Yaekashiwa, Masahiro ^a   Nakayama, Shoichi ^b   Ohnuma, Kazuya ^b   Sakai, Toshihiko ^b   Abe, Tatsuya ^b   Satoh, Ken ^b   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Takahashi, Tohru ^b   Nukiwa, Toshihiro ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DNA; HYDROXYPROLINE; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG TISSUE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

EID: 14444271598     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.6.9611057     Document Type: Article

References (54)

1. Nakamura, T., K. Nawa, and A. Ichihara. 1984. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122:1450-1459.
2. Nakamura, T., H. Teramoto, and A. Ichihara. 1986. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. U.S.A. 83:6489-6493.
3. Gohda, E., H. Tsubouchi, H. Nakayama, S. Hirano, O. Sakiyama, K. Takahashi, H. Miyazaki, S. Hashimoto, and Y. Daikuhara. 1988. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81: 414-419.
4. Nakamura, T., T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
5. Noji, S., K. Tashiro, E. Koyama, T. Nohno, K. Ohyama, S. Taniguchi, and T. Nakamura. 1990. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Commun. 173:42-47.
6. Ynagita, K., M. Nagaike, H. Ishibashi, Y. Niho, K. Matsumoto, and T. Nakamura. 1992. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 182:802-809.
7. Rubin, J. S., A. M. L. Chan, D. P. Bottaro, W. H. Burgess, W. G. Taylor, A. C. Cech, D. W. Hirschfield, J. Wong, T. Miki, P. W. Finch, and S. A. Aaronson. 1991. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Natl. Acad. Sci. U.S.A. 88:415-419.
8. Matsumoto, K., K. Hashimoto, K. Yoshikawa, and T. Nakamura. 1991. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp. Cell Res. 196:114-120.
9. Weidner, K. M., N. Arakaki, G. Hartmann, J. Vandekerckhove, S. Weingart, H. Rieder, C. Fonatsch, H. Tsubouchi, T. Hishida, Y. Daikuhara, and W. Birchmeier. 1991. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. U.S.A. 88:7001-7005.
10. Montesano, R., K. Matsumoto, T. Nakamura, and L. Onci. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908.
11. Tsarfaty, I., J. H. Resau, S. Rulong, I. Keydar, D. L. Faletto, and G. F. Vande Woude. 1992. The met proto-oncogene receptor and lumen formation. Science 257:1258-1261.
12. Matsumoto, K., and T. Nakamura. 1996. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. Tokyo 119:591-600.
13. Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birchmeier. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699-702.
14. Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702-705.
15. Ishiki, Y., H. Ohnishi, Y. Muto, K. Matsumoto, and T. Nakamura. 1992. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatol. 16:1227-1235.
16. Matsuda, Y., K. Matsumoto, T. Ichida, and T. Nakamura. 1995. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J. Biochem. Tokyo 118:643-649.
17. Igawa, T., K. Matsumoto, S. Kanda, Y. Saito, and T. Nakamura. 1993. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am. J. Physiol. 265:F61-F69.
18. Kawaida, K., K. Matsumoto, H. Shimazu, and T. Nakamura. 1994. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. U.S.A. 91:4357-4361.
19. Sakai, T., K. Satoh, K. Matsushima, S. Shindo, S. Abe, T. Abe, M. Motomiya, T. Kawamoto, Y. Kawabata, T. Nakamura, and T. Nukiwa. 1997. Hepatocyte growth factor in hronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am. J. Respir. Cell Mol. Biol. 16:388-397.
20. Yanagita, K., K. Matsumoto, K. Sekiguchi, H. Ishibashi, Y. Niho, and T. Nakamura. 1993. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268: 21212-21217.
21. Maeda, J., N. Ueki, T. Hada, and K. Higashino. 1995. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am. J. Respir. Crit. Care Med. 152:1587-1591.
22. Mason, R. J., C. C. Leslie, K. McCormick-Shannon, R. R. Deterding, T. Nakamura, J. S. Rubin, and J. M. Shannon. 1994. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 11:561-567.
23. Shiratori, M., G. Michalopoulos, H. Shinozuka, G. Singh, H. Ogasawara, and S. L. Katyal. 1995. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am. J. Respir. Cell Mol. Biol. 12:171-180.
24. Bottaro, D. P., J. S. Rubin, D. L. Faletto, A. M. L. Chan, T. E. Kmiecik, G. F. Vande Woude, and S. A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804.
25. Harrison, J. H., Jr., and J. S. Lazo. 1987. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 243:1185-1194.
26. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:467-470.
27. Woessner, J. F., Jr. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93:440-447.
28. Green, G. D., and K. Reagan. 1992. Determination of hydroxyproline by high pressure liquid chromatography. Anal. Biochem. 201:265-269.
29. Sokal, R. R., and F. J. Rohlf. 1995. Biometry. W. H. Freeman and Company, New York. 207-320.
30. Bros, P., and C. M. Miller. 1995. Hepatocyte growth factor: a multifunctional cytokine. Lancet 345:293-295.
31. Zarnegar, R., and G. K. Michalopoulos. 1995. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1177-1180.
32. Phan, S. H., R. S. Thrall, and C. Williams. 1981. Bleomycin-induced pulmonary fibrosis: effects of steroid on lung collagen metabolism. Am. Rev. Respir. Dis. 124:428-434.
33. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662-664.
34. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
35. Panos, R. J., J. S. Rubin, S. A. Aaronson, and R. J. Mason. 1993. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J. Clin. Invest. 92:969-977.
36. Burkhardt, A. 1989. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am. Rev. Respir. Dis. 140:513-524.
37. Katzenstein, A. L., and K. B. Askin. 1990. Idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis. In J. L. Bennington, editor. Surgical Pathology of Non-Neoplastic Lung Disease, 2nd ed. W. B. Saunders Company, Philadelphia. 58-96.
38. Meyer, K. C., and G. Raghu. 1995. Perspective and future advance on the diagnosis and treatment of idiopathic pulmonary fibrosis. In S. H. Phan and R. S. Thrall, editors. Pulmonary Fibrosis. Marcel Dekker, Inc., New York. 846-849.
39. Behr, J., B. Degenkolb, K. Maier, B. Braun, T. Beinert, F. Krombach, C. Vogelmeier, and G. Fruhmann. 1995. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur. Respir. J. 8:1286-1292.
40. Meyer, K. C., J. R. Lewandoski, J. J. Zimmerman, D. Nunley, W. J. Calhoun, and G. A. Dopico. 1991. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis: comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am. Rev. Respir. Dis. 144:580-585.
41. Kawabata, K., M. Suzuki, M. Sugitani, K. Imaki, M. Toda, and T. Miyamoto. 1991. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun. 177:814-820.
42. Leslie, C. C., K. McCormick-Shannon, and R. J. Mason. 1990. Heparin-binding growth factor stimulates DNA synthesis in rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 2:99-106.
43. Raaberg, L., E. NexØ, S. Buckley, W. Luo, M. L. Snead, and D. Warburton. 1992. Epidermal growth factor transcription, translation, and signal transduction by rat type II alveolar pneumocyte in culture. Am. J. Respir. Cell Mol. Biol. 6:44-49.
44. Leslie, C. C., K. McCormick-Shannon, R. J. Mason, and J. M. Shannon. 1993. Proliferation of rat alveolar epithelial cells in low density primary culture. Am. J. Respir. Cell Mol. Biol. 9:64-72.
45. Matsumoto, K., M. Kagoshima, and T. Nakamura. 1995. Hepatocyte growth factor as a potent survival factor for rat pheochromocytoma PC12 cells. Exp. Cell Res. 220:71-78.
46. Broekelmann, T. J., A. H. Limper, T. V. Colby, and J. A. McDonald. 1991. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A. 88:6642-6646.
47. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:29-43.
48. Border, W. A., and N. A. Noble. 1994. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1286-1292.
49. Khalil, N., O. Bereznay, M. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
50. Westergren-Thorsson, G., J. Hernnas, B. Sarnstrand, A. Oldberg, D. Heinegard, and A. Malmstrom. 1993. Altered expression of small proteoglycans, collagen, and transforming growth factor-β 1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92: 632-637.
51. Matsumoto, K., H. Tajima, H. Okazaki, and T. Nakamura. 1992. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β 1 and glucocorticoids. J. Biol. Chem. 267:24917-24920.
52. Okajima, A., K. Miyazawa, and N. Kitamura. 1993. Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. Eur. J. Biochem. 213:113-119.
53. Taipale, J., and J. Keski-Oja. 1996. Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-beta 1. J. Biol. Chem. 271:4342-4348.
54. Isaka, Y., D. K. Brees, K. Ikegaya, Y. Kaneda, E. Imai, N. A. Noble, and W. A. Border. 1996. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Medicine 2:418-423.